Particular catastrophic antiphospholipid syndrome, on the sole surgical site after breast reduction

J Plast Reconstr Aesthet Surg. 2013 Nov;66(11):e321-4. doi: 10.1016/j.bjps.2013.04.037. Epub 2013 May 14.

Abstract

A 20-year-old woman treated with vitamin K antagonist for antiphospholipid syndrome (APS) (pulmonary embolisms at age 15) was admitted for breast reduction after bridging therapy. At 2 days post-surgery haematomas appeared on the surgical site and anticoagulant therapy was withheld. She developed a skin and breast necrosis leading to the diagnosis of catastrophic APS. Despite medical treatment (anticoagulant therapy, corticosteroids and intravenous immunoglobulins) and surgery, necrosis continued. After 2 weeks of negative-pressure wound therapy (V.A.C.(®) Therapy™) the patient improved, mammary tissues were alive, well vascularised and budding. Breast reconstruction was then initiated. Artificial dermis graft (MatriDerm(®) 2 mm) was applied, and 3 weeks later the apposition of split-thickness skin graft on it. Six months later, results of the surgery were good and the patient was satisfied.

Keywords: Antiphospholipid syndrome; Mammaplasty; Negative-pressure wound therapy; Skin artificial; Skin necrosis; Skin transplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiphospholipid Syndrome / complications*
  • Antiphospholipid Syndrome / drug therapy
  • Breast / abnormalities
  • Breast / pathology*
  • Breast / surgery
  • Breast Diseases / etiology*
  • Female
  • Hematoma / etiology*
  • Hematoma / therapy
  • Humans
  • Hypertrophy / complications
  • Hypertrophy / surgery
  • Mammaplasty / adverse effects
  • Necrosis / etiology
  • Necrosis / therapy
  • Negative-Pressure Wound Therapy
  • Skin / pathology*
  • Skin Transplantation
  • Young Adult

Supplementary concepts

  • Gigantomastia